Torrent Pharmaceuticals Ltd. — Capital/Financing Update 2021

Mar 25, 2021

-torrent- E PHARmA

25[th ] March, 2021

The Dy. General Manager (Listing Dept.) BSE Limited, Corporate Relationship Dept., 1[st ] Floor, New Trading Ring, P. J. Towers, Dalal Street, Fort, Mumbai - 400 001 (BSE Scrip Code: 500420)

The Manager - Listing Dept., National Stock Exchange of India Ltd., Exchange Plaza, 5[th ] Floor, Plot No. C/1, G. Block, Bandra - Kurla Complex, Bandra (E), Mumbai - 400 051 (NSE Scrip Code: TORNTPHARM)

Dear Sir,

Sub.: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations")

We would like to inform you that the Company has subscribed to paitnership interest in ABCD Technologies LLP (to be renamed as IndoHealtb Services LLP).

The disclosure pursuant to Regulation 30 of the Listing Regulations and Clause A(l) of Part A, Schedule III of the Listing Regulations, is attached as per "Annexure I".

The above is for your information and record.

Thanking you,

Yours sincerely,

For TORRENT PHARMACEUTICALS LIMITED

==> picture [257 x 75] intentionally omitted <==

Encl: Annexure I

TORRENT PHARMACEUTICALS LIMITED

CIN: L24230GJ1972PLC002126

Reg.Office: Torrent House, Off Ashram Road, Ahmedabad - 380 009, India. Phone: +91 79 26599000, Fax: +917926582100, www.torrentpharma.com

m-torrent- w PHARmA

Annexure I

Disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 under Clause A(l) of Part A, Schedule III of the aforesaid regulations on subscription of partnership interest in .a.BCD Technologies LLP (to be renamed as lndoHealth Services LLP ) by the Company.

Requirements) Regulations, 2015 under Clause A(l) oregulations on subscription of partnership interest in .a.BlndoHealth Services LLP ) by the Company.a) Name of the target entity, detailsibrief i)Namsuch as size, turover etc.:ABCDlndoHrefrreii) DetThe Tlimited	Requirements) Regulations, 2015 under Clause A(l) oregulations on subscription of partnership interest in .a.BlndoHealth Services LLP ) by the Company.a) Name of the target entity, detailsibrief i)Namsuch as size, turover etc.:ABCDlndoHrefrreii) DetThe Tlimited	Requirements) Regulations, 2015 under Clause A(l) oregulations on subscription of partnership interest in .a.BlndoHealth Services LLP ) by the Company.a) Name of the target entity, detailsibrief i)Namsuch as size, turover etc.:ABCDlndoHrefrreii) DetThe Tlimited	f Part A, Schedule III of the aforesaCD Technologies LLP (to be renamed
	a) Name of the target entity, detailsibriefsuch as size, turover etc.:	i)NamABCDlndoHrefrreii) DetThe Tlimited	e of the Target entity:
			Technologies LLP (to be renamed aealthServices LLP), herein afed to as the Target entity.i i
			als of Target entty:arget entity is a recently incorporated''
			liability partnership (LLP) and ha
	b) Whether the acquisition would fall withinrelated patty transaction(s) and whether thepromoter/promoter group/group companieshave any interest in the entity being acquired?If yes, nature of interest and details thereof anclwhether the same is done at "Arms-length";	No.
	c) Industry to which the entity being acquiredbelongs;	Healthcare services.
	d) Objects and effects of acquisition (including Initiative with an objective to fcilitate, enablebut not limited to, disclosure of reasons for and promote effciency and Good Distributionacquisition of target entity, if its business is Practices('GDP')includingdigitizingoutside the main line of business of the listed healthcare infastructure in India, inter alia, inentity;support of the National Digital Health Missionof Government of India ('Business'). Theproposed LLP structure would inter alia ensuretransparent and effective competition to thebeneft ofpatients in India.
	e) Brief details of any governmental or None.regulatoryapprovalsrequiredfrtheacquisition;
	f) Indicative time period for completion of the NAacquisition;

TORRENT PHARMACEUTICALS LIMITED

CIN: L24230GJ1972PLC002126

Reg.Office : Torrent House, Off Ashram Road, Ahrnedabad - 380 009, India. Phone: +91 79 26599000, Fax : +91 79 265821 oci, www.torrentpharma.com

m;orrenr w PHRRmR

i) Percentage of shareholding I control acquired and/or number of shares acquired; j) Brief background about the entity acquired in terms of products/line of business acquired, date of incorporation, history of last 3 years turnover, country in which the acquired entity has presence and any other significant information (in brief);

Upto 20% share of profit/ loss in the Target entity.

The Target entity has been incorporated on 10 [111 ] February, 2021.

The Target entity is a newly incorporated LLP and has not commenced any business activities. The Target entity would engage in the Business through one or more subsidiary / LLP.

==> picture [73 x 75] intentionally omitted <==

TORRENT PHARMACEUTICALS LIMITED

CIN : L24230GJ1972PLC002126

Reg.Office: Torrent House, Off Ashram Road, Ahmedabad - 380 009, India. Phone: +91 79 26599000, Fax: +917926582100, www.torrentpharma.com